Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity

Nephron - Experimental Nephrology

Volumn 115, Issue 3, 2010, Pages

  Kamal, Fadia ^a   Yanakieva Georgieva, Nadezhda ^a   Piao, Honglan ^a   Morioka, Tetsuo ^a   Oite, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiotensin II receptor blockers; Calpain; Renin angiotensin aldosterone system; Streptozotocin induced diabetic nephropathy

Indexed keywords

CALPAIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN; SPECTRIN; STREPTOZOCIN; SYNAPTOTAGMIN I; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; NOS3 PROTEIN, RAT; TETRAZOLE DERIVATIVE; TRANSCRIPTION FACTOR RELA; VALINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; GLOMERULUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; KIDNEY TUBULE EPITHELIUM; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; RAT; STAINING; UREA NITROGEN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CALPAIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; INFLAMMATION; KIDNEY GLOMERULUS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; STREPTOZOCIN; TETRAZOLES; TRANSCRIPTION FACTOR RELA; VALINE;

EID: 77951215973     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313832     Document Type: Article

References (28)

1. Remuzzi G, Perico N, Macia M, Ruggenenti P: The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005; 99:S57-S65.
2. Mezzano S, Droguett A, Burgos ME, Ardiles LG, Flores CA, Aros CA, Caorsi I, Vío CP, Ruiz-Ortega M, Egido J: Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl 2003; 86:S64-S70.
3. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM: Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int 2000; 58: 1703-1710.
4. Portero-Otín M, Pamplona R, Boada J, Jové M, Gonzalo H, Buleon M, Linz W, Schäfer S, Tack I, Girolami JP: Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats. Biochem Biophys Res Commun 2008; 368: 528-535.
5. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T: Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005; 16: 3631-3641.
6. Mahmood J, Khan F, Okada S, Kumagai N, Morioka T, Oite T: Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis. Kidney Int 2006; 70: 1591-1598.
7. Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L: Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 2008; 102: 720-728.
8. Ikarashi K, Li B, Suwa M, Kawamura K, Morioka T, Yao J, Khan F, Uchiyama M, Oite T: Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int 2005; 67: 1925-1933.
9. Nakayama H, Oite T, Kawachi H, Morioka T, Kobayashi H, Orikasa M, Arakawa M, Shimizu F: Comparative nephritogenicity of two monoclonal antibodies that recognize different epitopes of rat Thy-1.1 molecule. Nephron 1998; 78: 453-463.
10. Oite T: Sensitive analysis of apoptosis using confocal laser scan microscopy. Exp Nephrol 2000; 8: 312-314.
11. Li B, Yao J, Morioka T, Oite T: Nitric oxide increases albumin permeability of isolated rat glomeruli via a phosphorylation-dependent mechanism. J Am Soc Nephrol 2001; 12: 2616-2624.
12. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
13. Li B, Yao J, Kawamura K, Oyanagi-Tanaka Y, Hoshiyama M, Morioka T, Gejyo F, Uchiyama M, Oite T: Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB. Kidney Int 2004; 66: 1939-1948.
14. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ: Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998; 14: 241-249.
15. Loscalzo J: Nitric oxide and vascular disease. N Engl J Med 1995; 333: 251-253.
16. Wang S, Peng Q, Zhang J, Liu L: Na + /H + exchanger is required for hyperglycaemia-induced endothelial dysfunction via calciumdependent calpain. Cardiovasc Res 2008; 80: 255-262.
17. Zhen J, Lu H, Wang XQ, Vaziri ND, Zhou XJ: Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 2008; 21: 28-34.
18. Hoshiyama M, Li B, Yao J, Harada T, Morioka T, Oite T: Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol 2003; 95:e62-e68.
19. Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB: Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11: 71-79.
20. De Vriese AS, Stoenoiu MS, Elger M, Devuyst O, Vanholder R, Kriz W, Lameire NH: Diabetes- induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide. Kidney Int 2001; 60: 202-210.
21. Ohishi K, Carmines PK: Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 1995; 5: 1559-1566.
22. Schnackenberg CG, Wilcox CS: The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 2001; 59: 1859-1864.
23. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H: Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 1998; 41: 1426-1434.
24. Grumbach IM, Chen W, Mertens SA, Harrison DG: A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol 2005; 39: 595-603.
25. Sánchez-López E, Rayego S, Rodrigues-Díez R, Rodriguez JS, Rodrigues-Díez R, Rodríguez- Vita J, Carvajal G, Aroeira LS, Selgas R, Mezzano SA, Ortiz A, Egido J, Ruiz-Ortega M: CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol 2009; 20: 1513-1526.
26. Stalker TJ, Gong Y, Scalia R: The calciumdependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes 2005; 54: 1132-1140.
27. Peltier J, Bellocq A, Perez J, Doublier S, Dubois YC, Haymann JP, Camussi G, Baud L: Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: evidence from calpastatintransgenic mice. J Am Soc Nephrol 2006; 17: 3415-3423.
28. Lee FT, Cao Z, Long DM, Panagiotopoulos S, Jerums G, Cooper ME, Forbes JM: Interactions between angiotensin II and NF-kappaB- dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol 2004; 15: 2139-2151.